A virtual pharma company tasked TEDOR with a tech transfer for a clinical trial supply of a product with an extremely low dose API of <1 mg per tablet. As the customer was also experiencing issues with their analytical methods, TEDOR was also asked to solve those issues. TEDOR’s teams successfully ran the R&D batches and solved all issues with the tablet Formulation. By changing, screening and selecting the appropriate grade of excipients, TEDOR was able to provide excellent uniformity for successful scale up for the customer’s Phase 2 clinical supply.

TEDOR Pharma is the right-sized CDMO for your upcoming projects. We're a specialized CDMO that helps companies like yours overcome the challenges of formulation, development, and commercialization of oral solid dose products.

To learn more about TEDOR Pharma and how we can help you overcome formulation challenges on your next oral solid dose project email Terry Novak.

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.